Cell Culture Market Share, Size, Trends, Industry Analysis Report, By Product; By Application; By End-Use; By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa); Segment Forecast, 2024 - 2032
- Published Date:Jan-2024
- Pages: 118
- Format: PDF
- Report ID: PM1013
- Base Year: 2023
- Historical Data: 2019-2022
Report Outlook
The global cell culture market size was valued at USD 18.11 billion in 2023. The market is anticipated to grow from USD 20.27 billion in 2024 to USD 50.22 billion by 2032, exhibiting the CAGR of 12.0% during the forecast period.
The growing demand for cell culture is expected to be driven by the increasing instances of chronic illness and R&D expenditure to develop monoclonal antibodies to cure these diseases.
Know more about this report: Request for sample pages
Awareness of cell-culture-based vaccines due to their effectiveness in treating certain diseases is also a significant factor contributing to the cell culture market growth. These vaccines replace conventional vaccines as they eliminate contamination and mismatch among strains during manufacturing.
In addition, an adequate supply of mammalian cells is required to manufacture these vaccines, which has increased their demand in many pharmaceutical companies and laboratories. Moreover, viral and fungal infections are treated with cell-based vaccines, influencing the industry growth.
The COVID-19 pandemic has influenced the growth of the cell culture market as it played a significant role in identifying many innovative diagnostic and treatment solutions to treat the SARS-CoV-2 virus. In addition, many pharmaceutical and biotechnological companies collaborated to develop antiviral drugs. For instance, GlaxoSmithKline plc partnered with Vir Biotechnology, Inc. to purchase 600,000 doses of sotrovimab, an investigational monoclonal antibody used in the early treatment of covid-19.
However, cell culture mainly relies on plastic consumables generating large amounts of plastic waste and polluting the environment, which is expected to hamper the market growth. Moreover, rising expenses to store high-quality samples and increasing equipment prices make it unaffordable for small-scale companies to perform this method which is expected to restrain industry growth.
Industry Dynamics
Growth Drivers
Rising infectious and chronic diseases such as influenza and cancer among the geriatric population are expected to drive the industry. Additionally, advancement in cell technology has resulted in the development of various drugs and personalized medicine. The cell behavior can be easily monitored and controlled in the micro-environment with the use of the 3D cell culture method, which allows the growth of two different cell populations with co-culture, which is effective for cancer treatment and therefore, propelling the market growth.
In addition, the adoption of regenerative therapies for transplantation in the healthcare sector is also contributing to the market growth owing to the treat organ and tissue failures. In addition, regenerative medicines also have a huge demand in baby boomers as it relieves pain caused by sprained ligament, strained muscles, and knee osteoarthritis, which is supporting the market growth.
Report Segmentation
The market is primarily segmented based on product, application, end-use, and region.
|
By Product |
By Application |
By End-Use |
By Region |
|
|
|
|
Know more about this report: Request for sample pages
Consumables Accounted for the Largest Share in 2021
Consumables segment accounted for the largest share, owing to their application in biopharmaceutical companies, academic research, and contract research institutes. In addition, the prevalence of many infectious diseases & chronic diseases such as cancer and stem cell transplant has increased the demand for personalized medicines which is expected to drive the market.
Moreover, the media segment is expected to lead the market as it eliminates contamination between samples and ensures precise cell culture, which has huge demand in life science, chemistry, and various end-use industries supporting the segment's growth.
Biopharmaceutical Production is Expected to Witness the Fastest Growth
Biopharmaceutical production is expected to witness the fastest growth over the forecast period due to the consumption of cell culture for medical screening and extensive compound synthesis. The increasing use of mammalian cell lines in the manufacturing pharmaceutical product is the primary factor influencing the market.
In addition, government support to develop cell culture-based vaccines due to rising monoclonal disorders and their effectiveness in curing this illness is also expected to accelerate the market.
Pharmaceutical and Biotechnological Companies is Expected to Lead the Market
The demand for pharmaceutical and biotechnological companies is expected to surge significantly over the forecast period owing to the increasing consumption of cell culture-based products in commercial as well as academic & research bio-production. The rising R&D expenditure to develop new antibody therapeutics and drugs are also a factor supporting the growth of the market.
Moreover, numerous companies are adopting artificial intelligence to monitor cell development and majorly for drug screening for cancer, tuberculosis, and many more. For instance, the researcher at Vancouver Prostate center developed an AI-driven App named SnapCyte for cell culture growth. The app collects the sample, monitors cell development over time, and displays accurate cell data; these factors support segment growth.
North America to Dominate and Witness the Fastest Growth over the Forecast Period
North America is the largest region for cell culture and is expected to continue its dominance over the forecast period owing to the rising chronic disease in the geriatric population. In addition, technological advancement in biopharmaceutical centers and government initiatives and policies to develop medical research is contributing to the segment growth.
Asia Pacific is expected to be the second largest region for the cell culture market on account of the rising government investment in the healthcare sector owing to increasing cases of cancer and diabetes, as well as brain injuries in developing economies such as India, China, and Japan.
Furthermore, major key companies focusing more on developing gene therapies create a lucrative opportunity for clinical research, which is likely to have a positive impact on revenue growth.
Competitive Insight
Some of the major players operating in the global market include Angus Chemical company, Adolf Kuhner, Biospherix, Caisson Laboratories Inc., Corning Incorporated, Dickinson and company, Danaher Corporation, Eppendorf AG, Fujifilm Irvine Scientific, Inc., Getinge AB, Meissner Filtration Products inc., Miltenyi Biotec, Himedia laboratories, Merck KGaA, Pan-Biotech GmbH, Lonza Group AG, SeraCare Life Sciences Inc., Stemcell Technologies Inc., Sartorius AG, ThermoFisher Scientific Inc.
Recent Developments
In September2022, Adolf Kuhner launched a new orbitally shaken bioreactor SB10-X which has a capacity of up to 3L. This vessel allows working with small units of 1.5-4.5L, which is used to perform cell culture.
In May 2022, Danaher Corporation partnered with Bespoke Gene Therapy Consortium to create gene therapy resources that are cost-efficient and more convenient for the research community to develop various drugs for rare diseases.
Cell Culture Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2024 |
USD 20.27 billion |
|
Revenue forecast in 2032 |
USD 50.22 billion |
|
CAGR |
12.0% from 2024 - 2032 |
|
Base year |
2023 |
|
Historical data |
2019 - 2022 |
|
Forecast period |
2024 - 2032 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2032 |
|
Segments covered |
By Product, By Application, By End-Use, By Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
|
Key companies |
Angus Chemical company, Adolf Kuhner, Biospherix, Caisson Laboratories Inc., Corning Incorporated, Dickinson and company, Danaher Corporation, Eppendorf AG, Fujifilm Irvine Scientific, Inc., Getinge AB, Meissner Filtration Products inc., Miltenyi Biotec, Himedia laboratories, Merck KGaA, Pan-Biotech GmbH, Lonza Group AG, SeraCare Life Sciences Inc., Stemcell Technologies Inc., Sartorius AG, ThermoFisher Scientific Inc. |
© 2024 Polaris Market Research and Consulting. All rights reserved
